每年專案
個人檔案
經歷
- 2023.08- 臺北醫學大學醫務管理學系主任
- 2020 臺北醫學大學醫務管理學系教授
- 2016 臺北醫學大學醫務管理學系副教授
指紋
查看啟用 Wei Pin Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Trends in the incidence of head and neck cancer: A nationwide population-based study
Yang, T. H., Xirasagar, S., Cheng, Y. F., Chen, C. S., Chang, W. P. & Lin, H. C., 5月 2023, 於: Oral Oncology. 140, 106391.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders
Chiu, Y. C., Chang, W. P., Tang, G. J., Lan, T. Y., Lee, K. Y. & Su, V. Y. F., 6月 2022, 於: Respiratory Medicine. 197, 106833.研究成果: 雜誌貢獻 › 文章 › 同行評審
1 引文 斯高帕斯（Scopus） -
Corrigendum to “Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders” [Respir. Med. 197 (2022) 106833] (Respiratory Medicine (2022) 197, (S0954611122000981), (10.1016/j.rmed.2022.106833))
Chiu, Y. C., Chang, W. P., Tang, G. J., Lan, T. Y., Lee, K. Y. & Su, V. Y. F., 8月 1 2022, 於: Respiratory Medicine. 200, 106893.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis
Adikusuma, W., Chou, W-H., Lin, M-R., Ting, J., Irham, L. M., Perwitasari, D. A., Chang, W-P. & Chang, W-C., 2022, 於: Biomedicines. 10, 1研究成果: 雜誌貢獻 › 文章 › 同行評審
8 引文 斯高帕斯（Scopus） -
Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
Adikusuma, W., Irham, L. M., Chou, W. H., Wong, H. S. C., Mugiyanto, E., Ting, J., Perwitasari, D. A., Chang, W. P. & Chang, W. C., 10月 2021, 於: Frontiers in Immunology. 12, 724277.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取8 引文 斯高帕斯（Scopus）
資料集
-
Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y. (Creator), Li, W. (Contributor), Chang, Y. (Creator), Peng, C. (Creator), Cheng, C. (Contributor), Chang, W. P. (Creator) & Chuang, C. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3642380.v1, https://figshare.com/collections/Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/3642380/1
資料集: Dataset
-
Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y. (Creator), Li, W. (Contributor), Chang, Y. (Creator), Peng, C. (Creator), Cheng, C. (Contributor), Chang, W. P. (Creator) & Chuang, C. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3642380_d1.v1, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/4462352/1
資料集: Dataset